Tagged with R

Taiwan Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global healthcare today.   From artificial intelligence to blockchain, the internet of things and regenerative medicine, Taiwanese firms – with the…

Puerto Rico Rodrick Miller was recently appointed CEO of Invest Puerto Rico, a government mandated but privately led non-for-profit organization tasked with positioning Puerto Rico as a competitive investment jurisdiction globally. Together with Gail Towers Nolan, Chief Strategy and Research Officer, he lays out his aggressive strategy to promote Puerto Rico’s assets…

Hungary Jānis Meikšāns, newly appointed general manager of Teva Hungary, speaks about his first few months in the country. Meikšāns goes on to elaborate on Hungary’s key positioning as a strategic affiliate for Teva with strong R&D and manufacturing operations. Additionally, he highlights Teva’s longstanding commitment to the country not only…

Hungary Dr Mátyás Szentiványi, Director General of the National Institute of Pharmacy and Nutrition (OGYEI), introduces the administrative authority and specifies his strategy to be an increasingly collaborative and communicative body of Hungary’s health regulation framework. Dr Szentiványi also goes on to comment on the current key challenges facing the sector,…

UAE Khaled Elrefae, Middle East and Africa Specialty Care Operations Head (GM) for Ipsen, highlights Ipsen’s impressive internationalization strategy and the success factors as well as rationale behind the company entrance to the MEA market with the newly established affiliate in UAE. He then discusses his mandate to drive a transformation…

UAE The United Arab Emirates Genetic Diseases Association (UAEGDA) was established in 2006 and aims to increase awareness programs in order to prevent the occurrence of common genetic disorders in the UAE and throughout the region. Dr. Maryam Matar is the founder of the UAEGDA, and she discusses the importance of…

Puerto Rico With four manufacturing plants in three sites, Becton, Dickinson and Company is a symbol of the Puerto Rico’s manufacturing prowess. José Sánchez, director of Reagent Manufacturing and operations manager for BD’s Cayey site, discusses the company’s 62-year history on the island and explains why it continues to be an attractive…

Hungary Dr. Péter Ofner, Former Director of the Gottsegen Hungarian Insititute of Cardiology, shares his insights on the cardiological capabilities of the institute, the epidemiological profile of the country, the collaborations with industry players, and outlooks for the future of this field as well as the country.   Hungary is a…

Puerto Rico Rolando Torres, executive vice president of global manufacturing for CooperVision, explains why Puerto Rico is a force to be reckoned with in medical device and pharmaceutical manufacturing. Moreover, he provides a general overview of their manufacturing operations and their large-scale efforts to make sustainable practices the new global standard.  …

Puerto Rico HRP Labs, the largest operator of pathology and specialized laboratories in Puerto Rico, is leading the way in the post-Hurricane Maria industry. Guillermo Villarmarzo, in-house legal counselor, and Gabriela Villarmarzo, chief compliance officer, discuss the company’s strategy to continue serving Puerto Rico’s healthcare system in benefit of the patients and…

Hungary Dr. György Blaskó, former President and Chairman of the Hungarian European Clinical Research Infrastructure Network, explains the role of the research network, the impact it has on the Hungarian clinical research environment, and the areas of improvement moving forward.   Domestic centralized health care and the presence of a single…

China PharmaBoardroom recently analysed the contents of 10 interviews conducted with country managers at multinational pharma companies in China. We found some underlying themes present in the majority of the interviews, giving an exclusive glimpse into what is currently at the top of the minds of pharma country managers in China.…